Pre-NDA meeting with FDA to discuss brilaroxazine’s path to approval for schizophrenia planned in Q4 2025 – – Potential NDA submission for ...
The one-night-only performance blends live instrumentation, immersive sound design and curated lighting effects into what the ...
Targeting Tear Function for Sustained Relief” convenes leading experts in ophthalmology and optometry to discuss evolving ...
Data expected H2 2026Rare liver disease with no approved treatment, typically concurrent with Inflammatory Bowel Disease (IBD)Second YAQ001 clinical study following successful cirrhosis trial LONDON, ...
Tweak these settings to unlock your Pixel's full photographic potential, from basic quality wins to Pro-level control.